Analysts see enormous long-term potential in these two penny stocks.
These two penny stock companies, while risky and volatile, have the potential to generate massive returns, according to Wall Street's price forecasts.
While these two penny stocks have the potential for exceptional returns, they also carry greater risk and volatility.
Lexaria Bioscience’s (NASDAQ: LEXX) path to becoming a global leader and innovator in drug delivery traces its origins to 2014, when CEO Chris Bunka redirected the company to its current business, focusing...
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has announced an addition to its board of directors; the company named industry veteran Catherine Turkel, PharmD, PhD,...
Management to host conference call and webcast at 4:30 pm ET IRVINE, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”)...